Brain Cancer
News and reporting on brain cancer.
Prediction Model IDs Brain Cancer Features That Contribute to Survival After CAR T-Cell Therapy
The model found that tumor surface area and age were inversely related to survival, while increased expression of IL-13Rα2 was a positive survival predictor.
Mustang Bio Initiates CAR T-Cell Therapy in Phase I Brain Tumor Trial
The trial will enroll up to 30 patients with leptomeningeal brain tumors, including glioblastoma, ependymoma, or medulloblastoma.
The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing.
Berg Advances BPM31510, Applies AI Platform to Biomarker Search in Phase II Brain Cancer Trial
Premium
The firm will collect multi-omics data from GBM patients and use its AI platform to home in on biomarkers of response to BPM31510.
Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test
The firm said its test can be used to evaluate blood samples from people who present with suspicious growths in the breast, lung, prostate, colon, or brain.